跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,396 条关于
“CorPath GRX”
全部
1,396
临床试验
631
药物
648
机构
29
资讯
88
去年
Robotic-Assisted Aneurysm Embolization Achieves 94% Technical Success Rate in Six-Month Follow-Up Study
去年
FDA's Evolving Stance on Biosimilar Interchangeability: A Shift Towards Streamlined Approvals
去年
Skyrizi Outpaces Humira in US Sales Amid Biosimilar Competition
去年
NRx Pharmaceuticals Plans NDA Submissions for NRX-100 and NRX-101 in Suicidal Depression
去年
NRx Pharmaceuticals Advances NRX-100 and NRX-101 for Suicidal Depression, Eyes 2024 NDA Filings
去年
NRx Pharmaceuticals' NRX-100 (Ketamine) Achieves Stability Milestone, NDA Filing on Track
去年
NRx Pharmaceuticals Submits NDA Section to FDA for NRX-100 (Ketamine) in Suicidal Depression
9个月前
GRI Bio's GRI-0621 Shows Promise in Phase 2a IPF Trial with Disease-Modifying Potential
3个月前
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
9个月前
NRx Pharmaceuticals Expands NRX-101 Development to Include Combination Therapy with Transcranial Magnetic Stimulation for Depression
第 1 页,共 9 页
上一页
下一页